Joachim Rothe is a Partner at EQT Life Sciences, having previously served as Managing Partner at Life Sciences Partners. See sector focus and contact routes.
Joachim Rothe is a Partner at EQT Life Sciences, having previously served as Managing Partner at Life Sciences Partners (LSP) from 2001 until the firm merged with EQT in 2022. Before joining LSP, he held senior roles at Roche, McKinsey, and MPM Capital, and holds a Ph.D. in Molecular Immunology from Freiburg University. His investment focus centers on early-stage life sciences and healthcare companies across Europe, with particular expertise in pharmaceuticals, medical devices, diagnostics, and healthtech. Rothe typically leads investments in the $11 million to $65 million range, with a sweet spot around $25 million, and has recorded 16 investments under his current profile. Notable portfolio companies include DNA Script, Binx Health, Nouscom, and Luxendo, where he has demonstrated proficiency in deal sourcing and technology transfer. He serves as a non-executive director on multiple boards, including SNIPR Biome and Ariceum Therapeutics, and has authored numerous articles in leading scientific publications such as Nature.
StartupFundraising tracks this investor record from SEC filings and announced rounds, updating focus, location and portfolio history as new data lands. Use it to gauge fit before an outreach, then widen the search to investors in Munich.
Investors like Joachim Rothe · Full investor directory · Investor access · Company funding database